Sign In
Buy OGN
$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon's steroid-free VTAMA (tapinarof) cream 1%, granted strong recommendation in American Academy of Dermatology guidelines for atopic dermatitis.
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit
07:23pm, Sunday, 06'th Jul 2025
NEW YORK , July 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 20
NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE: OGN). Such investors
NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company'
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
07:40am, Sunday, 06'th Jul 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Organon To Contact Him Directly To Discuss Their Options
NEW YORK and NEW ORLEANS , July 4, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have unti
NEW YORK, July 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30,
NEW YORK, July 04, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed ag
NEW YORK, July 04, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company'
Organon (OGN) Stock Dips While Market Gains: Key Facts
06:51pm, Thursday, 03'rd Jul 2025
The latest trading day saw Organon (OGN) settling at $9.96, representing a -1.87% change from its previous close.
Organon & Co. (NYSE: OGN) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
05:36pm, Thursday, 03'rd Jul 2025
PHILADELPHIA , July 3, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN
Organon & Co. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – OGN
04:29pm, Thursday, 03'rd Jul 2025
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit.
Deadline Alert: Organon & Co. (OGN) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
01:12pm, Thursday, 03'rd Jul 2025
LOS ANGELES, July 03, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf
OGN vs. MEDP: Which Stock Is the Better Value Option?
12:41pm, Thursday, 03'rd Jul 2025
Investors interested in Medical Services stocks are likely familiar with Organon (OGN) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
Lost Money on Organon & Co.(OGN)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
09:00am, Thursday, 03'rd Jul 2025
NEW YORK , July 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period
